Dosimetric Evaluation of 3-D Conformal and Intensity-modulated Radiotherapy for Breast Cancer after Conservative Surgery

  • Mansouri, Safae (Radiotherapy Oncology Center Talavera, Grupo IMO.) ;
  • Naim, Asmaa (Radiotherapy Oncology Center Talavera, Grupo IMO.) ;
  • Glaria, Luis (Radiotherapy Oncology Center Talavera, Grupo IMO.) ;
  • Marsiglia, Hugo (Radiotherapy Oncology Center Talavera, Grupo IMO.)
  • Published : 2014.06.15


Background: Breast cancers are becoming more frequently diagnosed at early stages with improved long term outcomes. Late normal tissue complications induced by radiotherapy must be avoided with new breast radiotherapy techniques being developed. The aim of the study was to compare dosimetric parameters of planning target volume (PTV) and organs at risk between conformal (CRT) and intensity-modulated radiation therapy (IMRT) after breast-conserving surgery. Materials and Methods: A total of 20 patients with early stage left breast cancer received adjuvant radiotherapy after conservative surgery, 10 by 3D-CRT and 10 by IMRT, with a dose of 50 Gy in 25 sessions. Plans were compared according to dose-volume histogram analyses in terms of PTV homogeneity and conformity indices as well as organs at risk dose and volume parameters. Results: The HI and CI of PTV showed no difference between 3D-CRT and IMRT, V95 gave 9.8% coverage for 3D-CRT versus 99% for IMRT, V107 volumes were recorded 11% and 1.3%, respectively. Tangential beam IMRT increased volume of ipsilateral lung V5 average of 90%, ipsilateral V20 lung volume was 13%, 19% with IMRT and 3D-CRT respectively. Patients treated with IMRT, heart volume encompassed by 60% isodose (30 Gy) reduced by average 42% (4% versus 7% with 3D-CRT), mean heart dose by average 35% (495cGy versus 1400 cGy with 3D-CRT). In IMRT minimal heart dose average is 356 cGy versus 90cGy in 3D-CRT. Conclusions: IMRT reduces irradiated volumes of heart and ipsilateral lung in high-dose areas but increases irradiated volumes in low-dose areas in breast cancer patients treated on the left side.


  1. Askoxylakis V, Thieke C, Pleger ST, et al (2010). Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer, 10, 105.
  2. Barnett GC, Wilkinson JS, Moody AM, et al (2011). The cambridge breast intensity-modulated radiotherapy trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol, 23, 662-73.
  3. Chie EK, Shin KH, Kim DY, et al (2009). Radiation pneumonitis after adjuvant radiotherapy for breast cancer: a Volumetric analysis using CT simulator. J Breast Cancer, 12, 73-8.
  4. Coon AB, Dickler A, Kirk MC, et al (2009). Tomotherapy and multifield intensity-modulated radiotherapy, planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy. Int J Radiat Oncol Biol Phys, 93, 57-63.
  5. Fisher B, Anderson S, Bryant J, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41.
  6. Fares A, Steve H, Catalina A, et al (2012). Phase II trial of 3D-conformal accelerated partial breast irradiation: Lessons learned from patients and physicians' evaluation. Radiation Oncology, 106, 703-7.
  7. Hepel JT, Tokita M, MacAusland SG, et al (2009). Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys, 75, 1290-6.
  8. Jae-Goo S, Jeong-Koo K, Won P, et al (2012). Dose-volume analysis of lung and heart according to respiration in breast cancer patients treated with breast conserving surgery. J Breast Cancer, 15, 105-10.
  9. Jagsi R, Ben-David MA, Moran JM, et al (2010). Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys, 76, 71-8.
  10. Liu YC, Zhou SB, Gao F, et al (2013).Phase II study on breast conservative surgery plus chemo- and radiotherapy in treating Chinese patients with early staged breast cancer. Asian Pac J Cancer Prev, 14, 3747-50.
  11. Lohr F, El-Haddad M, Dobler B, et al (2009). Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys, 74, 73-80.
  12. Nandi M, Mahata A, Mallick I, Achari R, Chatterjee S (2014). Hypofractionated radiotherapy for breast cancers - preliminary results from a tertiary care center in eastern India. Asian Pac J Cancer Prev, 15, 2505-10.
  13. Nesrin D, Laurie C, Rick L, et al (2007). Optimized dose coverage of regionaL lymph nodes in breast cancer: the role of intensity-modulated. Int J Radiation Oncology Biol Phys, 68, 1238-50
  14. Pignol JP, Olivoto I, Rakovitch E, et al (2008). A phase III multicentre clinical trial of Breast Intensity Modulate Radiation Therapy (IMRT) to reduce skin radiation side effects. J Clin Oncol, 26, 2085-92.
  15. Remouchamps VM, Vicini FA, Sharpe MB, et al (2003). Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys, 55, 392-406.
  16. Rajni A, Sethi A (2012). Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular node in a prone versus supine position. Radiother Oncol, 102, 74-81.
  17. Schubert LK, Gondi V, Sengbusch E, et al (2011). Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol, 100, 241-6.
  18. Smith BD, Pan IW, Shih YC, et al (2011). Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst, 103, 798-809.
  19. Varol U, Yildiz I, Alacacioglu A, Uslu R (2014). Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments. Asian Pac J Cancer Prev, 15, 1885-7.
  20. Veronesi U, Cascinelli N, Mariani L, et al (2002). Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 347, 1227-32.
  21. Vicini FA, Kestin L, Chen P, et al (2003). Limited-field radiation therapy in the management of early stage breast cancer. J Natl Canc Inst, 95, 1205-11.
  22. Volker R, Abdul A, Aziz Al, et al (2011). Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiation Oncology, 6, 392-406.
  23. Zhou SF, Shi WF, Meng D, et al (2012). Interoperative radiotherapy of seventy-two cases of early breast cancer patients during breast-conserving surgery. Asian Pac J Cancer Prev, 13, 1131-5.

Cited by

  1. Developing Multivariable Normal Tissue Complication Probability Model to Predict the Incidence of Symptomatic Radiation Pneumonitis among Breast Cancer Patients vol.10, pp.7, 2015,
  2. Planning Aspects of Volumetric Modulated Arc Therapy and Intensity Modulated Radio therapy in Carcinoma Left Breast - A Comparative Study vol.16, pp.4, 2015,
  3. Morphological Factors and Cardiac Doses in Whole Breast Radiation for Left-sided Breast Cancer vol.16, pp.7, 2015,
  4. Hybrid intensity-modulated radiation therapy (IMRT) simultaneous integrated boost (SIB) technique versus three-dimensional (3D) conformal radiotherapy with SIB for breast radiotherapy: a planning comparison vol.15, pp.02, 2016,
  5. Displacement of Surgical Clips during Postoperative Radiotherapy in Breast Cancer Patients Who Received Breast-Conserving Surgery vol.19, pp.4, 2016,